Literature DB >> 8542848

Development of reactive arthritis and resistance to erythromycin and rifampin in a foal during treatment for Rhodococcus equi pneumonia.

D G Kenney1, S C Robbins, J F Prescott, A Kaushik, J D Baird.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8542848     DOI： 10.1111/j.2042-3306.1994.tb04379.x

Source DB:  PubMed          Journal:  Equine Vet J        ISSN： 0425-1644            Impact factor:   2.888


× No keyword cloud information.
  7 in total

1.  The equine antimicrobial peptide eCATH1 is effective against the facultative intracellular pathogen Rhodococcus equi in mice.

Authors:  Margot Schlusselhuber; Riccardo Torelli; Cecilia Martini; Matthias Leippe; Vincent Cattoir; Roland Leclercq; Claire Laugier; Joachim Grötzinger; Maurizio Sanguinetti; Julien Cauchard
Journal:  Antimicrob Agents Chemother       Date:  2013-07-01       Impact factor: 5.191

2.  Emergence of rifampin-resistant Rhodococcus equi in an infected foal.

Authors:  S Takai; K Takeda; Y Nakano; T Karasawa; J Furugoori; Y Sasaki; S Tsubaki; T Higuchi; T Anzai; R Wada; M Kamada
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

3.  Characterization of mutations in the rpoB gene associated with rifampin resistance in Rhodococcus equi isolated from foals.

Authors:  M Fines; S Pronost; K Maillard; S Taouji; R Leclercq
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

4.  In vitro potential of equine DEFA1 and eCATH1 as alternative antimicrobial drugs in rhodococcosis treatment.

Authors:  Margot Schlusselhuber; Sascha Jung; Oliver Bruhn; Didier Goux; Matthias Leippe; Roland Leclercq; Claire Laugier; Joachim Grötzinger; Julien Cauchard
Journal:  Antimicrob Agents Chemother       Date:  2012-01-09       Impact factor: 5.191

5.  Emergence of Resistance to Macrolides and Rifampin in Clinical Isolates of Rhodococcus equi from Foals in Central Kentucky, 1995 to 2017.

Authors:  Laura Huber; Steeve Giguère; Nathan M Slovis; Craig N Carter; Bonnie S Barr; Noah D Cohen; Justine Elam; Erdal Erol; Stephan J Locke; Erica D Phillips; Jacqueline L Smith
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

6.  Resistance studies of erythromycin and rifampin for Rhodococcus equi over a 10-year period.

Authors:  T Buckley; E McManamon; S Stanbridge
Journal:  Ir Vet J       Date:  2007-12-01       Impact factor: 2.146

7.  Development of septic polysynovitis and uveitis in foals experimentally infected with Rhodococcus equi.

Authors:  Laura Huber; Steeve Giguère; Londa J Berghaus; Amanda Hanafi; Sarah Vitosh-Sillman; Sarah L Czerwinski
Journal:  PLoS One       Date:  2018-02-07       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.